(Q24654724)

English
No label defined

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Phase 1/2 double-blind, placebo-controlled, dose escalation, safety, and pharmacokinetic study of pagibaximab (BSYX-A110), an antistaphylococcal monoclonal antibody for the prevention of staphylococcal bloodstream infections, in very-low-birth-weight neonates (English)
0 references
0 references
Leonard E Weisman
0 references
Helen M Thackray
0 references
Joseph A Garcia-Prats
0 references
Mirjana Nesin
0 references
Joseph H Schneider
0 references
Jennifer Fretz
0 references
John F Kokai-Kun
0 references
James J Mond
0 references
William G Kramer
0 references
July 2009
0 references
53
0 references
7
0 references
2879-86
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit